Drug Patents owned by Bausch And Lomb Inc

1. Drug name - BEPREVE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8877168 BAUSCH AND LOMB INC Aqueous liquid preparations and light-stabilized aqueous liquid preparations Jul, 2023

(9 months from now)

US8784789 BAUSCH AND LOMB INC Aqueous liquid preparations and light-stabilized aqueous liquid preparations Jan, 2025

(2 years from now)

Drugs and Companies using BEPOTASTINE BESILATE ingredient

Treatment: NA

Dosage: SOLUTION/DROPS;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
1.5% SOLUTION/DROPS;OPHTHALMIC Prescription

2. Drug name - LOTEMAX SM

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10596107 BAUSCH AND LOMB INC Ophthalmic suspension composition Dec, 2036

(14 years from now)

Drugs and Companies using LOTEPREDNOL ETABONATE ingredient

Treatment: Treatment of post-operative inflammation and pain following ocular surgery

Dosage: GEL;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
0.38% GEL;OPHTHALMIC Prescription

3. Drug name - LUMIFY

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9259425 BAUSCH AND LOMB INC Compositions and methods for eye whitening Jul, 2030

(7 years from now)

US8293742 BAUSCH AND LOMB INC Preferential vasoconstriction compositions and methods of use Jul, 2030

(7 years from now)

Drugs and Companies using BRIMONIDINE TARTRATE ingredient

Treatment: Relieves redness of the eye due to minor eye irritations

Dosage: SOLUTION/DROPS;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
0.025% SOLUTION/DROPS;OPHTHALMIC Over the counter

4. Drug name - XIPERE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8636713 BAUSCH AND LOMB INC Methods and devices for drug delivery to ocular tissue using microneedle May, 2027

(4 years from now)

US9636332 BAUSCH AND LOMB INC Methods and devices for the treatment of ocular diseases in human subjects Nov, 2033

(11 years from now)

US9937075 BAUSCH AND LOMB INC Apparatus and methods for ocular injection May, 2034

(11 years from now)

Drugs and Companies using TRIAMCINOLONE ACETONIDE ingredient

Treatment: Treatment of macular edema associated with uveitis

Dosage: SUSPENSION;INJECTION

More Information on Dosage
Strength Dosage Availability
40MG/ML SUSPENSION;INJECTION Prescription

availability in other generic markets.

Click on the highlighted region to filter.